2011 Scrip 100: Experimental collaboration model to drive Merck cancer research
This article was originally published in Scrip
In May 2010, Merck & Co launched an oncology collaborative trials network (Onconet) with leading international cancer research centres to speed up the development of its drug and vaccine candidates. The global research sites will lead the design and conduct of Phase 0 to Phase IIa clinical studies of Merck's investigational oncology candidates. Merck says that every year, the network will enrol approximately 1,200 patients in 30 to 40 clinical trials.
You may also be interested in...
UK engineering firm Dyson, best known for its vacuum cleaners, fans and hand driers, plans to make 10,000 specially designed ventilators under a UK government contract.
Production of ventilators is up by tens of thousands of units across Europe, but the supply chain is likely to come under strain with further expansion.
The proceeds from the investment will enable Nyxoah to prepare for the IDE pivotal trial of the Genio system in the US, and accelerate market access and commercialization activities in Europe, Australia and New Zealand.